Related Experiment Video

Updated: Jan 20, 2026

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.9K

EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer

Elif Asik1,2, Yeliz Akpinar3,4, Ayse Caner1

  • 1Department of Experimental Therapeutics, The University of Texas-MD Anderson Cancer Center, Houston, TX 77054, USA.

Nanomedicine (London, England)
|August 22, 2019
PubMed

Insights

Eukaryotic elongation factor 2 kinase (EF2K) is highly expressed in BRCA1-mutated breast cancer, correlating with poor survival. Targeting EF2K with novel nanoparticle-delivered siRNA therapy suppressed tumor growth in preclinical models.

Area of Science:

  • Oncology
  • Nanotechnology
  • Molecular Biology

Background:

  • BRCA1 mutations are linked to aggressive breast cancer subtypes.
  • Identifying novel therapeutic targets is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the role of EF2K in BRCA1-mutated breast cancer.
  • To evaluate the efficacy of EF2K-targeted nanotherapy.

Main Methods:

  • Development of silica-coated cobalt-ferrite (CoFe) nanoparticles for siRNA delivery.
  • Assessment of EF2K expression in BRCA1-mutated breast cancer patients.
  • In vitro evaluation of EF2K silencing on cancer cell behavior.
  • In vivo studies using orthotopic xenograft models.

Main Results:

  • EF2K is overexpressed in 78.5% of BRCA1-mutated breast cancers, associated with poor survival and metastasis.
  • EF2K silencing inhibited cancer cell proliferation, migration, and invasion.
  • CoFe-nanoparticle delivered siRNA achieved sustained EF2K knockdown in vivo.
  • Tumor growth was suppressed in xenograft models treated with CoFe-siRNA-nanoparticles.

Conclusions:

  • EF2K represents a promising molecular target for BRCA1-mutated breast tumors.
  • CoFe-based siRNA nanotherapy offers a novel therapeutic strategy for targeting EF2K.
Keywords:
BRCA1EF2 kinasePARP inhibitorangiogenesisbreast cancergene-silencing therapyinvasionmetastasismigrationnanoparticles

More Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA108:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

15.0K
Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

23.9K

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.0K
Mutations01:39

Mutations

Overview
94.4K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
43.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K